Author

Patricia H.A. Halkes

Observed names: P H A Halkes, P. H. A. Halkes, P.H.A. Halkes, PHA Halkes, Patricia H A Halkes, Patricia H. A. Halkes, Patricia HA Halkes, Patricia Halkes, Patricia P.H.A. Halkes

Observed institutions: Utrecht University, University of Zurich, Erasmus MC, University Medical Center Utrecht, Noordwest Ziekenhuisgroep, Medisch Centrum Haaglanden, University Hospital Zurich, Amsterdam Neuroscience, Ziekenhuis Bethesda, Ziekenhuis Groep Twente, Amsterdam University Medical Centers, De Hoogstraat Revalidatie, Medisch Centrum Alkmaar

OpenAlex ID: A5111961120

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

2020 · René Post, Menno R Germans, et al. · The Lancet · 192

PDF

Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk

2008 · P H A Halkes, L J Gray, et al. · Journal of Neurology Neurosurgery & Psychiatry · 85

Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

2022 · Sophie A van den Berg, Simone M Uniken Venema, et al. · The Lancet Neurology · 65

PDF

Direct Costs of Surgical Clipping and Endovascular Coiling of Unruptured Intracranial Aneurysms

2006 · Patricia H.A. Halkes, Marieke J.H. Wermer, et al. · Cerebrovascular Diseases · 51

Prehospital Detection of Large Vessel Occlusion Stroke With EEG

2023 · Maritta N. van Stigt, Eva A. Groenendijk, et al. · Neurology · 37

PDF

Classification of Cause of Death After Stroke in Clinical Research

2006 · Patricia H.A. Halkes, Jan van Gijn, et al. · Stroke · 31

Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study

2024 · Thomas P Zonneveld, Sarah E Vermeer, et al. · The Lancet Neurology · 21

Large Subcortical Infarcts

2006 · Patricia H.A. Halkes, L. Jaap Kappelle, et al. · Stroke · 18

PDF

Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage

2022 · Maud A. Tjerkstra, René Post, et al. · Neurology · 16

PDF

Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin

2008 · P H A Halkes, J van Gijn, et al. · Journal of Neurology Neurosurgery & Psychiatry · 15

Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke

2016 · Adrien E. Groot, Ivo N. van Schaik, et al. · Journal of Neurology · 13

PDF

Screening and Care for Emotional and Cognitive Problems After Ischemic Stroke

2025 · Jos P.L. Slenders, Renske M. Van Den Berg-Vos, et al. · Neurology · 9

Presentation outside office hours does not negatively influence treatment times for reperfusion therapy for acute ischemic stroke

2020 · A. E. Groot, H. de Bruin, et al. · Journal of Neurology · 8

PDF

Pre- and Interhospital Workflow Times for Patients With Large Vessel Occlusion Stroke Transferred for Endovasvular Thrombectomy

2021 · Laura C. C. van Meenen, Frank Riedijk, et al. · Frontiers in Neurology · 6

Prevention With Low-Dose Aspirin Plus Dipyridamole in Patients With Disabling Stroke

2010 · Diederik W.J. Dippel, Lisette Maasland, et al. · Stroke · 5

PDF

ESPRIT trial – Authors' reply

2006 · PHA Halkes, J van Gijn, et al. · The Lancet · 4

PDF

Anticoagulants, Aspirin and Dipyridamole in the Secondary Prevention of Cerebral Ischaemia: Which Is the Best for Which Patient?

2007 · P.H.A. Halkes, A. Algra · Cerebrovascular Diseases · 2

[No role for oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)].

2008 · E L L M De Schryver, P H A Halkes · PubMed · 1

Oral Anticoagulation in Secondary Prevention After Cerebral Ischemia of Arterial Origin

2005 · P.H.A. Halkes · Stroke · 1

PDF

[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].

2008 · A Algra, E L L M De Schryver, et al. · PubMed

Interpretation of ESPRIT in the FASTER trial

2008 · Ale Algra, Jan van Gijn, et al. · The Lancet Neurology

Geen plaats voor orale antistollingsbehandeling (streef-INR: 2,0-3,0) na een 'transient ischaemic attack' of een herseninfarct van arteriële oorsprong; de 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)*

2008 · E. L. L. M. De Schryuer, Patricia H.A. Halkes · Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank

Subject Index Vol. 24, Suppl. 1, 2007

2007 · Carlos A. Molina, Andrei V. Alexandrov, et al. · Cerebrovascular Diseases

PDF

Title Page / Table of Contents

2007 · Carlos A. Molina, Andrei V. Alexandrov, et al. · Cerebrovascular Diseases

PDF

ESPRIT (European/Australasian Stroke Prevention in Reversible Ischaemia Trial) and related studies

2004 · Patricia H.A. Halkes · Utrecht University Repository (Utrecht University)

Works count: 27

Citation count: 772

H-index: 12

I10-index: 12